VALNEVA (EPA:VLA) Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate
Directive transparence : information réglementée
31/01/2022 22:15
08/08/2022 22:45
26/07/2022 15:51
06/07/2022 14:36
24/06/2022 18:00
23/06/2022 16:00
23/06/2022 15:16
14/04/2022 12:50
10/02/2022 15:41
04/02/2022 19:30
31/01/2022 22:15